Anwar-Mohamed A, Degenhardt OS, El Gendy MA, Seubert JM, Kleeberger SR, El-Kadi AO
The blockade of ERK1/2 activation by U0126 (a MAPK kinases inhibitor) attenuated the IRE1 level, suggesting that ERK1/2 activation causes ER stress activation in PFOS-treated RTCs (Fig
This concern relates to a common physiological principle known as down-regulation , where the body reduces its sensitivity to a hormone when it receives a strong external signal for an extended period
Semaglutide and tirzepatide
If side effects do not improve or become serious, tell your doctor or the healthcare team right away
Triggered all-active metal organic framework: Ferroptosis machinery contributes to the apoptotic photodynamic antitumor therapy